NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.

Private
SuzhouHealthcare & Life Sciences

Last Round

Series A

Jun 1, 2022

Total Funding Raised

$15.34M

Company Overview

Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. is a biotechnology company that focuses on the research and development of novel small molecule drugs for the treatment of immunology and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

small molecule therapeuticsaryl hydrocarbon receptor agonistAhR agonistinflammatory bowel diseaseIBDulcerative colitisdrug discoverybiotech licensingCDK12 inhibitorSRPK1 inhibitorEGFR inhibitorautoimmune diseaseclinical-stage biotechdrug pipelinepharma partnering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 1, 2022
AngelMar 1, 2021

Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Investors

Notable investors and investment history

Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. investors
InvestorRounds
HighLight CapitalSeries A
Kaitai CapitalAngel
Anlong FundAngel

Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Allianthera (Suzhou) Biopharmaceuticals Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou
Year Founded2020
Last FundingJun 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.